Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
1
NMPA:1
Drug Approvals
Sucroferric Oxyhydroxide Chewable Tablets
- Product Name
- 维福瑞
- Approval Number
- 国药准字HJ20233131
- Approval Date
- Feb 21, 2023
NMPA
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)No trials found
News
No news found